Literature DB >> 21445628

Orlans HO, Hornby SJ, Bowler IC (2011) In vitro antibiotic susceptibility patterns of bacterial keratitis isolates in Oxford, UK: a 10-year review. Eye Jan 21 [Epub ahead of print] PMID 21252952.

Stephen Kaye, Rose Gilbert, Henri Sueke, Timothy Neal.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21445628     DOI: 10.1007/s00417-011-1667-z

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


× No keyword cloud information.
  11 in total

1.  An in vitro investigation of synergy or antagonism between antimicrobial combinations against isolates from bacterial keratitis.

Authors:  Henri Sueke; Stephen B Kaye; Timothy Neal; Amanda Hall; Stephen Tuft; Christopher M Parry
Journal:  Invest Ophthalmol Vis Sci       Date:  2010-03-24       Impact factor: 4.799

2.  Emerging fluoroquinolone resistance in bacterial keratitis: a 5-year review.

Authors:  M H Goldstein; R P Kowalski; Y J Gordon
Journal:  Ophthalmology       Date:  1999-07       Impact factor: 12.079

3.  Ciprofloxacin-resistant Pseudomonas keratitis.

Authors:  P Garg; S Sharma; G N Rao
Journal:  Ophthalmology       Date:  1999-07       Impact factor: 12.079

Review 4.  The evolution of antibiotic therapy for bacterial conjunctivitis and keratitis: 1970-2000.

Authors:  J Baum; M Barza
Journal:  Cornea       Date:  2000-09       Impact factor: 2.651

5.  Minimum inhibitory concentrations of standard and novel antimicrobials for isolates from bacterial keratitis.

Authors:  Henri Sueke; Stephen Kaye; Timothy Neal; Conor Murphy; Amanda Hall; Dianne Whittaker; Stephen Tuft; Christopher Parry
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-12-17       Impact factor: 4.799

6.  Does in vitro susceptibility predict clinical outcome in bacterial keratitis?

Authors:  Aiyin Chen; Lalitha Prajna; Muthiah Srinivasan; Rajendran Mahalakshmi; John P Whitcher; Stephen McLeod; Thomas M Lietman; Nisha R Acharya
Journal:  Am J Ophthalmol       Date:  2008-01-22       Impact factor: 5.258

7.  Gatifloxacin and moxifloxacin: an in vitro susceptibility comparison to levofloxacin, ciprofloxacin, and ofloxacin using bacterial keratitis isolates.

Authors:  Regis P Kowalski; Deepinder K Dhaliwal; Lisa M Karenchak; Eric G Romanowski; Francis S Mah; David C Ritterband; Y Jerold Gordon
Journal:  Am J Ophthalmol       Date:  2003-09       Impact factor: 5.258

8.  Influence of fluoroquinolone susceptibility on the therapeutic response of fluoroquinolone-treated bacterial keratitis.

Authors:  Kirk R Wilhelmus; Robert L Abshire; Barry A Schlech
Journal:  Arch Ophthalmol       Date:  2003-09

9.  Fourth-generation fluoroquinolone-resistant bacterial keratitis.

Authors:  Vishal Jhanji; Namrata Sharma; Gita Satpathy; Jeewan Titiyal
Journal:  J Cataract Refract Surg       Date:  2007-08       Impact factor: 3.351

10.  Bacterial susceptibility to topical antimicrobials and clinical outcome in bacterial keratitis.

Authors:  Stephen Kaye; Stephen Tuft; Timothy Neal; Derek Tole; John Leeming; Francisco Figueiredo; Malcolm Armstrong; Peter McDonnell; Andrew Tullo; Christopher Parry
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-08-13       Impact factor: 4.799

View more
  1 in total

1.  [Effectiveness of initial antibiotic therapy for treatment of contact lens-related bacterial keratitis].

Authors:  B Steger; L Speicher; W Philipp; T Gasser; E Schmid; N Bechrakis
Journal:  Ophthalmologe       Date:  2014       Impact factor: 1.059

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.